March Biosciences
Biotechnology
2450 Holcombe Blvd
16 employees
- Employees
- 16
- Contacts
- 4
- Emails
- 4
- Phones
- 4
March Biosciences Overview
- Headquarters
- 2450 Holcombe Blvd
- Website
- www.march.bio
- Industry
- Biotechnology
- Employees
- 16
- Funding
- 200.0K
Keywords
About March Biosciences
March Biosciences, Inc is a clinical-stage cell therapy company with a mission to transform patient care in the most challenging hematological malignancies. March Bio's lead asset is at the end of Phase I trials for T-cell malignancies, diseases with a dismal prognosis that is currently unaddressed by CAR-T and targeted therapy technologies. The company's pipeline is designed to expand on these early successes to more broadly impact other high-challenge cancers.
March Biosciences Contact Details
- People in AeroLeads
- 4
- With contact data
- 4
- Email contacts
- 4
- 100.0% coverage
- Phone contacts
- 4
- 100.0% coverage
March Biosciences Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Aaron Vernon | Washington Dc-baltimore Area, United States |
Email
Phone
|
|
| Dr Alice Bexon | CEO Bexon Clinical and Leader at Ectd Submit | Montclair, New Jersey, United States |
Email
Phone
|
| Peter Olagunju | Driven Biotech Executive - Board Director | Cambridge, Massachusetts, United States |
Email
Phone
|
| Thomas Luby | Chief Innovation Officer at Texas Medical Center | Houston, Texas, United States |
Email
Phone
|
Employees by Management Level
Executive
2 profiles
Director
1 profile
Compare Similar Companies to March Biosciences
Neurogene Inc.
Biotechnology
Cellipont Bioservices
Biotechnology Research
Be Biopharma
Biotechnology
Alpha-9 Oncology
Biotechnology Research
AvenCell
Biotechnology
Portal Innovations
Biotechnology Research
4BIO Capital
Venture Capital And Private Equity Principals
NKILT Therapeutics, Inc.
Biotechnology Research
BioHouston
Biotechnology Research
Courier Therapeutics
Biotechnology Research